Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system
Yamin Shu, Xucheng He, Pan Wu et al. · Frontiers in Public Health · 2022
Full textCC BY
Toxicology
Filters3 filters applied
Status
- No notice
- From publisher notices and Retraction Watch. Not checked means nobody has looked yet.
Year
1 paperQuestions on this topic